Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
To-go cocktails in North Carolina: How does it work?
Recommended
What to know about Shearon Harris Nuclear Plant, emergency plans
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Origin Therapeutics
Recent news which mentions Origin Therapeutics
Origin Therapeutics Attaches Clairvoyant To Its Portfolio, Fueling Fast Market Strategy For Psilocybin Therapy
July 07, 2022
Tags
Benzinga
Psychedelics
Management
From
Benzinga
New Psychedelic Investment Opportunity: Look For "ORIG" (Origin Therapeutics) On The CSE Starting June 6
June 02, 2022
Tickers
CSE
IPOS
Tags
Global
Market News
Cannabis
From
Benzinga
Yet Another Company Joins The World Of Psychedelic Retreats, This Time In Canada
May 17, 2022
Tickers
SILFF
Tags
News
SILFF
Dimensions Health Centres Inc
From
Benzinga
Psyched: Atai Launches 'Salvia Divinorum' Subsidiary, Mindset, Psilera and Wesana's Preclinical Trials, Origin Raises $5M
August 16, 2021
Tickers
ATAI
AWKNF
MSSTF
WSNAF
Tags
Origin Therapeutics
AWKNF
Penny Stocks
From
Benzinga
Origin Therapeutics Will Invest $6.5M In Psychedelics Startups
August 13, 2021
Tags
psychedelics
News
Origin Therapeutics
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.